The University of Virginia Cancer Center Received NCI Comprehensive Designation
On Feb. 1, 2022, University of Virginia Cancer Center announced it had been awarded a Comprehensive Cancer Center…
Study of Penn patients with decade-long leukemia remissions after CAR T cell therapy revealed new details about persistence of personalized ‘Living Drug’ cells
On Feb. 2, 2022, a new analysis of the first two patients treated in a clinical trial with…
Anixa Biosciences announced patient dosing of investigational vaccine candidate in first-of-its-kind preventative breast cancer vaccine study
On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
On Oct. 15, 2021, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Tecentriq (atezolizumab)…
the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewal
On Oct. 4, 2021, the Fred & Pamela Buffett Cancer Center announced it had successfully renewed its National…
Biotechnology | Diagnostics | Disease | Environmental | Genomics | Life Science News | NIH | Oncology
NIH study illuminated origins of lung cancer in never smokers
On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
FDA approved Merck’s hypoxia-inducible factor-2 alpha inhibitor WELIREG (belzutifan)
On Aug. 13, 2021, Merck announced that the U.S. Food and Drug Administration (FDA) had approved WELIREG, an…
Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved first targeted therapy for subset of non-small cell lung cancer
On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…
UTSW researchers identified new gene involved in breast cancer growth
On Jan. 12, 2021, a team researchers from the University of Texas Southwestern (UTSW) announced they had identified…
American Cancer Society reported largest one-year drop in cancer mortality from 1991-2017
On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved first adjuvant therapy for most common type of lung cancer
On Dec. 18, 2020, the the U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Tagrisso (osimertinib) as the…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Oncology | Radiology | Therapeutics
AI detected COVID-19 on chest X-rays faster and with more accuracy than radiologists
On Nov. 24, 2020, Northwestern University researchers announced they had developed a new artificial intelligence (A.I.) platform that…
Agilent received expanded FDA approval for PD-L1 IHC 22C3 pharmDx in triple-negative breast cancer
On Nov. 13, 2020, Agilent Technologies announced it had received U.S. Food and Drug Administration (FDA) approval for…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics of breast and ovarian cancer
On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…
Seagen announced closing of $1.0 billion stock sale to Merck
On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…
Fred Hutch completed move-in of Lake Union Steam Plant
On Nov. 9, 2020, after more than two years of reconstruction efforts, scientists from the Fred Hutchinson Cancer…
Pascal Biosciences and SoRSE Technology announced partnership for cannabinoid drug development and cancer clinical trials
On Sept. 14, 2020, Pascal Biosciences and SoRSE Technology announced they had entered into a collaborative research agreement…
Biology | Biotechnology | COVID-19 | Diagnostics | Disease | Infectious Disease | Life Science News | Oncology | Therapeutics
NanoString announced new GeoMx COVID-19 Consortium, part of the GeoMx Translational Leadership Network
On Sept. 9, 2020, NanoString Technologies announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN…
Biotechnology | COVID-19 | Disease | Infectious Disease | Life Science News | Oncology | Therapeutics
University of Oxford study described which cancer patients are more vulnerable to COVID-19
On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Oncology
Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in Singapore
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…
Disease | Life Science News | NIH | Oncology
NIH study linked cigarette smoking to higher stroke risk in African Americans
On Jun. 10, 2020, African Americans who smoke are nearly 2.5 times more likely to have a stroke…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Therapeutics
FDA approved first targeted therapy to treat aggressive form of lung cancer
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
The FDA approved new therapy for triple negative breast cancer
On Apr. 22, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy),…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Tim and Mary Boyle gave $10 million to OHSU for joint center for biomedical data science
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…